Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe ...
Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe ...
While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.
Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis ...
The investigational GSK-3-beta inhibitor elraglusib can extend overall survival when added to standard first-line ...
A retrospective analysis finds that patients with lung-only metastatic pancreatic cancer have better overall survival, are ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults combined, cancer is the second most common cause of death (after heart disease).
Daraxonrasib received FDA breakthrough therapy designation for metastatic PDAC with KRAS G12 mutations, expediting its development. The designation is based on promising phase 1 trial results, with ...
When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results